Jacqueline H. Starrett

Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer

Caterina Bartolacci, Cristina Andreani, Gonçalo Vale et al. · Nature Communications · 2022 · 170 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Anti–PD-L1 and anti-CD73 combination therapy promotes T cell response to EGFR-mutated NSCLC

Eric Tu, Kelly McGlinchey, Jixin Wang et al. · JCI Insight · 2022 · 109 citations · Full text

Life Sciences, Immunology, Oncology +17

The EGFR Exon 19 Mutant L747-A750>P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma

Anna Truini, Jacqueline H. Starrett, Tyler F. Stewart et al. · Clinical Cancer Research · 2019 · 64 citations · Full text

Medicine, Oncology, Pharmacology +16

Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance <i>EGFR</i> Mutations

Jacqueline H. Starrett, Alexis Guernet, Maria Emanuela Cuomo et al. · Cancer Research · 2020 · 60 citations · Full text

Medicine, Oncology, Pharmacology +16

Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations

Michael J. Grant, Jacqueline V. Aredo, Jacqueline H. Starrett et al. · Clinical Cancer Research · 2023 · 40 citations · Full text

Medicine, Oncology, Pharmacology +16